{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:47:52Z","timestamp":1778791672544,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Premi Fi de residencia: Emili Letang","award":["052012"],"award-info":[{"award-number":["052012"]}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["CTQ2015-63919-R"],"award-info":[{"award-number":["CTQ2015-63919-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1329-6","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T08:44:20Z","timestamp":1497516260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Differing specificities and isotypes of anti-citrullinated peptide\/protein antibodies in palindromic rheumatism and rheumatoid arthritis"],"prefix":"10.1186","volume":"19","author":[{"given":"Sonia","family":"Cabrera-Villalba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gomara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ruiz-Esquide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Victoria","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Inciarte-Mundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimon","family":"Sanmart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"1329_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9343(92)90177-D","volume":"93","author":"PA Guerne","year":"1992","unstructured":"Guerne PA, Weisman MH. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med. 1992;93:451\u201360.","journal-title":"Am J Med"},{"key":"1329_CR2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/keg268","volume":"42","author":"G Salvador","year":"2003","unstructured":"Salvador G, Gomez A, Vinas O, Ercilla G, Canete JD, Munoz-Gomez J, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology (Oxford). 2003;42:972\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"1329_CR3","first-page":"1240","volume":"33","author":"AS Russell","year":"2006","unstructured":"Russell AS, Devani A, Maksymowych WP. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol. 2006;33:1240\u20132.","journal-title":"J Rheumatol."},{"key":"1329_CR4","first-page":"992","volume":"35","author":"A Powell","year":"2008","unstructured":"Powell A, Davis P, Jones N, Russell AS. Palindromic rheumatism is a common disease: comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients. J Rheumatol. 2008;35:992\u20134.","journal-title":"J Rheumatol"},{"key":"1329_CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1756-185X.2012.01739.x","volume":"15","author":"A Khabbazi","year":"2012","unstructured":"Khabbazi A, Hajialiloo M, Kolahi S, Soroosh M, Esalatmanesh K, Sharif S. A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int J Rheum Dis. 2012;15:427\u201330.","journal-title":"Int J Rheum Dis"},{"key":"1329_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2006.058933","volume":"66","author":"A Vannini","year":"2007","unstructured":"Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, et al. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis. 2007;66:511\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3899\/jrheum.120568","volume":"39","author":"R Sanmarti","year":"2012","unstructured":"Sanmarti R, Cabrera-Villalba S, Gomez-Puerta JA, Ruiz-Esquide V, Hernandez MV, Salvador G, et al. Palindromic rheumatism with positive anticitrullinated peptide\/protein antibodies is not synonymous with rheumatoid arthritis. A long-term follow-up study. J Rheumatol. 2012;39:1929\u201333.","journal-title":"J Rheumatol"},{"key":"1329_CR8","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3899\/jrheum.120995","volume":"39","author":"SJ Katz","year":"2012","unstructured":"Katz SJ, Russell AS. Palindromic rheumatism: a pre-rheumatoid arthritis state? J Rheumatol. 2012;39:1912\u20133.","journal-title":"J Rheumatol"},{"key":"1329_CR9","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","volume":"63","author":"LA Stadt van de","year":"2011","unstructured":"van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 2011;63:3226\u201333.","journal-title":"Arthritis Rheum"},{"key":"1329_CR10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","volume":"69","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69:1554\u201361.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR11","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","volume":"13","author":"H Kokkonen","year":"2011","unstructured":"Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Ronnelid J, et al. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther. 2011;13:R13.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR12","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","volume":"58","author":"A Ioan-Facsinay","year":"2008","unstructured":"Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum. 2008;58:3000\u20138.","journal-title":"Arthritis Rheum"},{"key":"1329_CR13","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessi\u00e8re","year":"2001","unstructured":"Masson-Bessi\u00e8re C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177\u201384.","journal-title":"J Immunol"},{"key":"1329_CR14","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Despr\u00e9s N, Lapointe E, van der Heijden A, Lora M, Senshu T, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther. 2004;6:R142\u201350.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR15","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","volume":"7","author":"A Kinloch","year":"2005","unstructured":"Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R1421\u20139.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR16","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1021\/jm0701932","volume":"50","author":"ML Perez","year":"2007","unstructured":"Perez ML, Gomara MJ, Ercilla G, Sanmarti R, Haro I. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med Chem. 2007;50:3573\u201384.","journal-title":"J Med Chem"},{"key":"1329_CR17","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1021\/jm200563u","volume":"54","author":"M Malakoutikhah","year":"2011","unstructured":"Malakoutikhah M, Gomara MJ, Gomez-Puerta JA, Sanmarti R, Haro I. The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis. J Med Chem. 2011;54:7486\u201392.","journal-title":"J Med Chem"},{"key":"1329_CR18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3899\/jrheum.131545","volume":"41","author":"S Cabrera-Villalba","year":"2014","unstructured":"Cabrera-Villalba S, Ramirez J, Salvador G, Ruiz-Esquide V, Hernandez MV, Inciarte-Mundo J, et al. Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonography study according to anticitrullinated protein antibody status. J Rheumatol. 2014;41:1650\u20135.","journal-title":"J Rheumatol"},{"key":"1329_CR19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/art.37911","volume":"65","author":"L Barra","year":"2013","unstructured":"Barra L, Scinocca M, Saunders S, Bhayana R, Rohekar S, Racape M, et al. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum. 2013;65:1439\u201347.","journal-title":"Arthritis Rheum"},{"key":"1329_CR20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/art.38022","volume":"65","author":"KA Young","year":"2013","unstructured":"Young KA, Derber LA, Hughes-Austin JM, Wagner CA, Sokolove J, Weisman MH, et al. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein\/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum. 2013;65:1995\u20132004.","journal-title":"Arthritis Rheum"},{"key":"1329_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","volume":"70","author":"LA Stadt van de","year":"2011","unstructured":"van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011;70:128\u201333.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","volume":"69","author":"JJ Luime","year":"2010","unstructured":"Luime JJ, Colin EM, Hazes JM, Lubberts E. Does antimutated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A sytematic review. Ann Rheum Dis. 2010;69:337\u201344.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landewe R, Lie BA, Odegard S, et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis. 2010;69:345\u20131.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/annrheumdis-2011-200668","volume":"71","author":"L Arlestig","year":"2012","unstructured":"Arlestig L, Mullazehi M, Kokkonen H, Rocklov J, Ronnelid J, Dahlqvist SR. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis. 2012;71:825\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1329_CR25","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1186\/ar3524","volume":"13","author":"P Suwannalai","year":"2011","unstructured":"Suwannalai P, Willemze A, van Toorn L, Stoeken-Rijsbergen G, Levarht N, Drijfhout JW, et al. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA. Arthritis Res Ther. 2011;13:R195.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR26","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.22279","volume":"54","author":"KN Verpoort","year":"2006","unstructured":"Verpoort KN, der Zijde CM J-v, der Voort EA P-v, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, et al. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum. 2006;54:3799\u2013808.","journal-title":"Arthritis Rheum."},{"key":"1329_CR27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2011-200421","volume":"71","author":"A Willemze","year":"2012","unstructured":"Willemze A, B\u00f6hringer S, Knevel R, Levarht EW, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, et al. The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis. 2012;71:268\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1329_CR28","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar4322","volume":"15","author":"JJ Beers van","year":"2013","unstructured":"van Beers JJ, Willemze A, Jansen JJ, Engbers GH, Salden M, Raats J, et al. ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression. Arthritis Res Ther. 2013;15(5):R140.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-015-0786-z","volume":"17","author":"J Heemst van","year":"2015","unstructured":"van Heemst J, Trouw LA, Nogueira L, van Steenbergen HW, van der Helm-van Mil AH, Allaart CF, et al. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting. Arthritis Res Ther. 2015;17:276.","journal-title":"Arthritis Res Ther"},{"key":"1329_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","volume":"69","author":"WH Bos","year":"2010","unstructured":"Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis. 2010;69:490\u20134.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1329-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T08:44:39Z","timestamp":1497516279000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1329-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1329-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]},"article-number":"141"}}